[1. Hashimoto K, Matsumoto S, Yamada M, Satoh T, Mori M. Liver X Receptor-α gene expression is positively regulated by thyroid hormone. Endocrinology. 2007; 148:4667-75.10.1210/en.2007-015017628006]Search in Google Scholar
[2. Zelcer N, Tontonoz P. Liver X receptors as integrators of metabolic and inflammatory signalling. J Clin Invest. 2006; 116:607-14.10.1172/JCI27883138611516511593]Open DOISearch in Google Scholar
[3. Jamroz-Wioeniewska A, Wójcicka G, Horoszewicz K, Be³towski J. Liver X receptors (LXRs). Part II: Nonlipid effects, role in pathology, and therapeutic implications. Postepy Hig Med Dosw. 2007; 61:760-85.]Search in Google Scholar
[4. Gerbod-Giannone M, Li Y, Holleboom A, Han S, Hsu L, Tabas I, et al. TNF-α induces ABCA1 through NF-κB in macrophages and in phagocytes ingesting apoptotic cells. Proc Natl Acad Sci U S A. 2006; 103:3112-7.10.1073/pnas.0510345103141389716492740]Open DOISearch in Google Scholar
[5. Tacer KF, Kuzman D, Seliskar M, Pompon D, Rozman D. TNF-α interferes with lipid homeostasis and activates acute and proatherogenic processes. Physiol Genomics. 2007; 31:216-27.10.1152/physiolgenomics.00264.200617566076]Open DOISearch in Google Scholar
[6. Kwon SH, Nam JI, Kim SH, Kim JH, Yoon JH, Kim KS. Kaempferol and quercetin, essential ingredients in ginkgo biloba extract, inhibit interleukin-1β-induced MUC5AC gene expression in human airway epithelial cells. Phytother Res. 2009; 23:1708-12.10.1002/ptr.281719367675]Open DOISearch in Google Scholar
[7. Arai H, Uchida K, Nakamura K. Effect of ascorbate on acrolein modification of very low density lipoprotein and uptake of oxidized apolipoprotein E by hepatocytes. Biosci Biotech Bioch. 2005; 69:1760-2.10.1271/bbb.69.176016195596]Open DOISearch in Google Scholar
[8. Garcia-Lafuente A, Guillamon E, Villares A, Rostagno MA, Martinez JA. Flavonoids as anti-inflammatory agents: Implications in cancer and cardiovascular disease. Inflamm Res. 2009; 58:537-52.10.1007/s00011-009-0037-319381780]Open DOISearch in Google Scholar
[9. Wang Y, Moser AH, Shigenaga JK, Grunfeld C, Feingold KR. Downregulation of liver X receptor-α in mouse kidney and HK-2 proximal tubular cells by LPS and cytokines. J Lipid Res. 2005; 46:2377-87.10.1194/jlr.M500134-JLR20016106051]Open DOISearch in Google Scholar
[10. Ng DL, Tie SW, Ong PC, Lim WS, Tengku-Muhammad TS, Choo, QC, Chew CH. Rapamycin pre-treatment abrogates Tumour Necrosis Factor-α down-regulatory effects on LXR-α and PXR mRNA expression via inhibition of c-Jun N-terminal kinase 1 activation in HepG2 cells [Internet]. Electron J Biotechn. 2011; 14. Available from http://www.ejbiotechnology.info/index.php/ejbiotechnology/article/viewFile/v14n3-9/ 1296 DOI:10.2225/vol14-issue3-fulltext-910.2225/vol14-issue3-fulltext-9]Open DOISearch in Google Scholar
[11. Kim HK, Park HR, Lee JS, Chung TS, Chung HY, Chung J. Down-regulation of iNOS and TNF-α expression by kaempferol via NF-κB inactivation in aged rat gingival tissues. Biogerontology. 2007; 8: 399-408.10.1007/s10522-007-9083-917278014]Open DOISearch in Google Scholar
[12. Hämalainen M, Nieminen R, Vuorela P, Heinonen M, Moilanen E. Anti-inflammatory effects of flavonoids: genistein, kaempferol, quercetin and daidzein inhibit STAT-1 and NF-κB activations, whereas flavone, isorhamnetin, naringenin and pelargonidin inhibit only NF-κB activation along with their inhibitory effect on iNOS expression and NO production in activated macrophages. Mediators Inflamm. 2007; 2007: 45673.10.1155/2007/45673]Search in Google Scholar
[13. Gomes A, Fernandes E, Lima JLFC, Mira L, Corvo ML. Molecular mechanisms of anti-inflammatory activity mediated by flavonoids. Curr Med Chem. 2008; 15: 1586-605.10.2174/092986708784911579]Open DOISearch in Google Scholar
[14. Bowie AG, O’Neill LAJ. Vitamin C inhibits NF-κB activation by TNF via the activation of p38 mitogenactivated protein kinase. J Immunol. 2000; 165:7180-8.10.4049/jimmunol.165.12.7180]Search in Google Scholar
[15. Mu oz E, Bl zquez MV, Ortiz C, Gomez-Di z C, Navas P. Role of ascorbate in the activation of NF-κB by tumor necrosis factor-α in T-cells. Biochem J. 1997; 325:23-8.10.1042/bj3250023]Search in Google Scholar
[16. Kaul D, Baba M. Genomic effect of vitamin ‘C’ and statins within human mononuclear cells involved in atherogenic process. Eur J Clin Nutr. 2005; 59:978-81.10.1038/sj.ejcn.1602203]Open DOISearch in Google Scholar
[17. Kaya F, Belin S, Bourgeois P, Micaleff J, Blin O, Fontes M. Ascorbic acid inhibits PMP22 expression by reducing cAMP levels. Neuromuscul Disord. 2007; 17: 248-53.10.1016/j.nmd.2006.12.008]Open DOISearch in Google Scholar
[18. McRae MP. The efficacy of vitamin C supplementation on reducing total serum cholesterol in human subjects: a review and analysis of 51 experimental trials. J Chiropr Med. 2006; 5:2-12.10.1016/S0899-3467(07)60127-X]Open DOISearch in Google Scholar
[19. Aulinskas TH, Van der Westhuyzen DR, Coetzee GA. Ascorbate increases the number of low density lipoprotein receptors in cultured arterial smooth muscle cells. Atherosclerosis 1983; 47:159-71.10.1016/0021-9150(83)90152-1]Open DOISearch in Google Scholar
[20. Laffitte BA, Joseph SB, Walczak R, Pei L, Wilpitz DC, Collins JL, et al. Autoregulation of the human liver X receptor α promoter. Mol Cell Biol. 2001; 21:7558-68. 10.1128/MCB.21.22.7558-7568.20019992711604492]Open DOISearch in Google Scholar